Daniel Garrett
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Medication Adherence and Compliance 2
-
- Pharmaceutical Practices and Patient Outcomes 3
- Co-authors
- Benjamin M. BlumlLeslie MartinJuan Carlos Suárez SerratoEric OhrnToni FeraWilliam M. EllisIvan IvanovJames W. Roberts
- Journals
- Journal of the American Pharmacists Association (3 papers)The Review of Economic Studies (1 paper)Review of Financial Studies (1 paper)AEA Papers and Proceedings (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
Daniel Garrett
13 papers receiving 377 citations
Peers
Comparison fields: 5 of 61
- Family Practice 128
- Geriatrics and Gerontology 211
- Applied Microbiology and Biotechnology 15
- Endocrinology, Diabetes and Metabolism 91
- Accounting 60
Countries citing papers authored by Daniel Garrett
This map shows the geographic impact of Daniel Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Garrett more than expected).
Fields of papers citing papers by Daniel Garrett
This network shows the impact of papers produced by Daniel Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Garrett. The network helps show where Daniel Garrett may publish in the future.
Co-authorship network
The 15 scholars most cited alongside Daniel Garrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 15 | |
| 3 | 2022 | 13 | |
| 4 | 2021 | 19 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 54 | |
| 7 | 2019 | 4 | |
| 8 | 2015 | 5 | |
| 9 | The business case for ending homelessness: having a home improves health, reduces healthcare utilization and costs. | 2012 | 9 |
| 10 | Net Tuition and Net Price Trends in the United States: 2000-2009. | 2011 | 2 |
| 11 | 2008 | 88 | |
| 12 | 2005 | 136 | |
| 13 | 2003 | 59 | |
| 14 | 2003 | 4 |
About Daniel Garrett
Daniel Garrett is a scholar working on Family Practice, Geriatrics and Gerontology, Accounting, Economics and Econometrics and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 417 indexed citations. Recurring topics across this work include Corporate Taxation and Avoidance (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Diabetes Management and Education (2 papers), Medication Adherence and Compliance (2 papers), Corporate Finance and Governance (2 papers), Fiscal Policy and Economic Growth (2 papers), Homelessness and Social Issues (1 paper) and Politics, Economics, and Education Policy (1 paper). The work is most often cited by research in Family Practice (128 citations), Geriatrics and Gerontology (211 citations), Applied Microbiology and Biotechnology (15 citations), Endocrinology, Diabetes and Metabolism (91 citations) and Accounting (60 citations). Daniel Garrett has collaborated with scholars based in United States. Frequent co-authors include Benjamin M. Bluml, Leslie Martin, Juan Carlos Suárez Serrato, Eric Ohrn, Toni Fera, William M. Ellis, Ivan Ivanov, James W. Roberts, Kevin Roberts and E. Mark Curtis. Their work appears in journals such as Journal of the American Pharmacists Association, The Review of Economic Studies, Review of Financial Studies, AEA Papers and Proceedings and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.